SEC Form 4 · accession 0001348324-15-000120

LDR HOLDING CORP · LDRH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, European Sales, Medical

Period of report

Dec 29, 2015

Accepted (ET)

Dec 30, 2015 · 5:17 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348324

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 29, 2015	M	8,214	$5.0325	A	562,905	D
Common Stock^F1	Dec 29, 2015	M	15,558	$12.1153	A	578,463	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Medical Class A Warrants (right to buy)^F2,F3	—	Dec 29, 2015	M	8,214	D	Jul 10, 2013	Jun 30, 2022	Common Stock	8,214	4,792	D
Medical Class A Warrants (right to buy)^F4,F3	—	Dec 29, 2015	M	15,558	D	Oct 11, 2013	Jun 30, 2023	Common Stock	15,558	28,519	D

F1The exercise price was converted from Euros to U.S dollars based on the prior business day currency exchange rate.
F2The warrant becomes exercisable for 25% of the shares granted upon one year from the vesting commencement date of July 10, 2012, then in thirty-six equal monthly installments thereafter. The exercise price is 4.59 EURO.
F3The BCE Warrants are exercisable for Class A Stock of LDR Medical S.A.S., the Issuer's majority-owned subsidiary, which are in turn convertible into the Issuer's Common Stock on a 1 for 5.80087 basis.
F4The warrant becomes exercisable in forty-eight equal monthly installments following the vesting commencement date of September 11, 2013. The exercise price is 64.11 EURO.